Jason Paul Steik - 06 Aug 2026 Form 4 Insider Report for Pennant Group, Inc. (PNTG)

Reporting relationship: Chief Clinical Officer
Issuer ticker: PNTG
Reported as of: 06 Aug 2026
Net transaction value: -$53,700
SEC form: 4
Accepted by SEC: 10 Aug 2026, 15:48:46 UTC
Prior SEC filing: 12 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kirk Cheney, as attorney in fact

Key filing fact

Jason Paul Steik filed Form 4 for Pennant Group, Inc. (PNTG) on 10 Aug 2026.

Key facts

This page summarizes Jason Paul Steik's Form 4 filing for Pennant Group, Inc. (PNTG).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Aug 2026, 15:48.

Change

Previous filing in this sequence was filed on 12 Mar 2026.
Current net transaction value: -$53,700.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002078374 Primary reporting owner

Steik Jason Paul

Relationship: Chief Clinical Officer
Address: 1675 E. RIVERSIDE DR, SUITE 150, EAGLE
Signature: /s/ Kirk Cheney, as attorney in fact
Signature date: 10 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PNTG transaction

Common Stock

Sale

Transaction value: $53,700
Shares: -1,394
Change %: -8.4%
Price: $38.52
Shares after: 15,106
Date: 06 Aug 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).